1.The relationship between plasma metabolic profiling and platelets activation on acute myocardium infarction patients
Chungang GU ; Lei ZHANG ; Hua KANG ; Shuye LIU
Chinese Journal of Laboratory Medicine 2015;(5):325-328
Objective To identity the characteristic metabolites of platelets activation by Plasma metabolic Profiling in acute myocardium infarction ( AMI ) patients.Methods From August 2012 to February 2013, samples in three groups were collected at Tianjin Third Central hospital, including AMI group (25 clinically diagnosis myocardial infarction, 14 male, 11 female, average age 67 ±13 ) , control group(A) and simulation platelet activation group(B) (A and B group composed of 29 health volunteers, 11 male 18 female, average age 65 ±12 ) .After collagen platelet activation on B group, HPLC-LTQ Orbitrap XL MS platform was used to analyze the serum metabolic profiling in three groups respectively.Principal component analysis ( PCA) model and partial least squares-discriiminate analysis ( OPLS-DA) model were established to select characteristic metabolites in A and B group, and then tested in X group to find common ions.Results 20 characteristic metabolites were selected in A and B group.3 different lysophosphatidyl choline, sphingosine 1-phosphate, ethanol amine amides, sphingosine choline phosphate, thromboxane, 14-methyl hexadecanoic acid showed the same changing trend and were significant different between B group and AMI group.Conclusions Characteristic ions selected by metabolic profiling technology had significant distinguishing ability for AMI patients and health control.They may provide early diagnosis for AMI.
2.Clinical efficacy of surgery for chronic subdural hematoma assisted by rigid neuroendoscope
Qing ZHU ; Zhongyong WANG ; Tan ZHANG ; Chungang DAI ; Liang XU ; Chao SUN ; Ailin CHEN ; Qing LAN
China Journal of Endoscopy 2017;23(6):52-57
Objective To discuss the clinical efficacy of surgery for chronic subdural hematoma assisted by rigid neuroendoscope and its surgical techniques. Methods Clinical data of 161 patients with chronic subdural hematoma from August 2009 to December 2015 was analyzed retrospectively. 74 of them experienced surgeries assisted by rigid neuroendoscope (endoscope group) and other 87 cases were operated without neuroendoscope (routine group) during the same period. Results Although there were significant difference in operative duration between the two groups, complications, ratio of total removal of hematoma after surgery, postoperative inpatient duration and recurrent rate of hematoma were more advantageous in endoscope group. The operative duration of endoscope group with (112.68 ± 34.86) min was longer than that of routine group with (74.11 ± 28.23) min (t = 7.75, P = 0.000), while the postoperative inpatient duration of endoscope group with (8.23 ± 2.01) d was shorter than that of another group with (10.79 ± 5.02) d (t = -4.12, P = 0.000). There were no surgical associated complications in endoscope group, but 1 patient in routine group experienced intracerebral hematoma of frontal lobe and associated aphemia. Total removal of hematoma was confirmed in endoscope group with 98.65% (73/74), which was higher than that in routine group with 86.21% (75/78) (χ2 = 8.34, P = 0.004). Hematoma recurrence was found in 16 cases of routine group (18.39%), but more superiority in endoscope group with 1.35% (χ2 = 12.29, P = 0.000). Outpatient follow-up was carried out in all patients from 6 to 38 months with an average duration of 30.06 months. In 17 cases with recurrent hematoma during follow-up, 15 of them were cured by a second surgery, and another 2 patients were cured by atorvastatin. Conclusion As a simple, safe and effective technique, the application of rigid neuroendoscope during surgery for chronic subdural hematoma is more advantage than routine surgery. A self-made suction with adjustable soft curved tip is suitable for such procedure.
3.The mechanical characteristics and early-stage clinical effects of double bundle anterior cruciate ligament reconstruction with femoral direct fiber insertion
Xianxiang XIANG ; Chungang ZHANG ; Weiming WANG
Chinese Journal of Orthopaedics 2020;40(7):397-407
Objective:To investigate the finite element analysis and early-stage clinical effects of double bundle anterior cruciate ligament (ACL) reconstruction with femoral direct fiber insertion.Methods:From June 2016 to June 2017, a total of 26 cases of ACL reconstruction were analyzed retrospectively, including 15 males and 11 females, mean age 30.5±4.6 years. All the patients underwent ACL reconstruction by the same operator. The early-stage clinical effects were evaluated by the finite element analysis, pivot shift test, Lachman test, preoperative and postoperative IKDC score, Lyshlom score, KT-2000, 3D-CT and MRI.Results:The finite element analysis confirmed theoretically that the double bundle ACL reconstruction with femoral direct fiber insertion could restore the stability and biomechanics of knee effectively. The results of pivot shift test were negative, and the Lachman test were negative except one first-stage positive after operation. 3D-CT showed that the bone tunnel was located in the direct fiber area. MRI showed clearly the ACL of double bundle after operation. Lysholm score increased from 56.5±3.6 pre-operation to 61.9±3.2 at three months after operation, and up to 88.5±2.0 two years after operation with statistically significant difference ( F=824.72, P<0.001). IKDC score increased from 48.3±2.8 before operation to 58.0±2.0 at three months after operation, and to 92.5±2.6 at two years after operation with statistically significant difference ( F=2 256.66, P<0.001). KT-2000 side-side difference decreased from 5.6±0.7 mm to 1.6±0.5 mm at three months after operation, and to 1.5±0.6 mm at two years after operation with statistically significant difference ( F=389.14, P<0.001). Conclusion:The double bundle ACL reconstruction with femoral direct fiber insertion can effectively restore the stability and the biomechanical environment of knee joint with satisfied early-stage clinical effects.
4.Simultaneous determination of 10 constituents in Huoxiang zhengqi soft capsules by UPLC-MS/MS
Qiang ZHANG ; Chungang ZHANG ; Yong GUO ; Lan CHENG
China Pharmacy 2022;33(3):287-292
OBJECTIVE To establish the ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry method for simultaneous determination of liquiritin , naringin, hesperidin, neohesperidin, nobiletin, atractylenolide Ⅲ , imperatorin,honokiol,isoimperatorin and magnolol in Huoxiang zhengqi soft capsules. METHODS Twelve batches of Huoxiang zhengqi soft capsules were extracted by ultrasonic extraction with ethanol. The determination was performed on Ultimate XB-C 18 column with mobile phase consisted of acetonitrile - 0.1% formic acid solution for gradient elution at the flow rate of 0.4 mL/min. The column temperature was 30 ℃. The electrospray ionization source was applied to carry out the positive and negative ion scanning with multiple react ion monitoring mode. RESULTS The linear range of liquiritin ,naringin,hesperidin,neohesperidin, nobiletin,atractylenolide Ⅲ ,imperatorin,honokiol,isoimperatorin and magnolol were 1.64-52.40,1.73-55.20,1.54-49.20, 1.71-54.80,1.74-55.60,4.19-134.00,1.51-48.40,1.61-51.60,1.80-57.60,1.74-55.60 ng/mL(r≥0.999 5),respectively. The limits of quantitation were 0.41,0.43,0.19,0.43,0.11,1.05,0.19,0.40,0.45,0.11 ng/mL,respectively. RSDs of precision ,stability (24 h)and repeatability tests were all lower than 6%. Average recoveries were 102.42%,98.65%,98.34%,101.48%,96.74%, 100.40%,104.92%,98.53%,99.50%,105.40%(RSD=1.34%-5.44%,n=9). The contents of the above 10 constituents in 12 batches of Huoxiang zhengqi soft capsules were 201.21-287.89,5.03-20.37,1 465.56-1 988.35,5.35-9.01,217.09-306.44,1.91- 16.17,1 081.59-1 377.12,2 388.34-2 915.13,341.26-397.45 and 7 633.47-8 976.99 μg/g,respectively. CONCLUSIONS The established method for content determination is convenient ,sensitive and accurate ,which can be used for the quality control and evaluation of Huoxiang zhengqi related preparations.
5.Investigation in vitro Release Rate and in vivo Pharmacokinetics of Resveratrol/Hydroxypropyl- β-Cyclodextrin/Chitosan Sustained-release Pellets in Rats
Chenchen YU ; Chungang ZHANG ; Li YIN ; Yixuan ZHOU ; Lan CHENG ; Tingguo KANG
China Pharmacy 2019;30(19):2603-2607
OBJECTIVE: To investigate in vitro release rate and in vivo pharmacokinetics of Resveratrol/hydroxypropyl-β- cyclodextrin/chitosan sustained-release pellets (RES/HP-β-CD/Chitosan) in rats. METHODS: In vitro release rate of RES raw materials, RES-HP-β-CD complexes (RES/HP-β-CD) and RES/HP-β-CD/Chitosan in water within 12 h were investigated by paddle method. The pharmacokinetic characteristics of RES raw materials, RES/HP-β-CD and RES/HP-β-CD/Chitosan were compared within 720 min after intragastric administration. RESULTS: Compared with RES raw materials, in vitro release rate of RES/HP-β-CD was increased significantly, and 120 min accumulative release rate reached 87%. Compared with RES/HP-β-CD, in vitro release rate of RES/HP-β-CD/Chitosan were relieved significantly; release time prolonged significantly; 12 h accumulative release rate was 72%. The pharmacokinetic parameters of RES raw materials, RES/HP-β-CD and RES/HP-β-CD/Chitosan included that cmax were 473.3, 2 492.2, 590.5 ng/mL; t1/2 were 2.6, 0.5, 4.6 h; AUC0-12 h were 514.7, 824.6, 2 778.5 ng·h/mL. Compared with RES raw materials, relative bioavailability of RES/HP-β-CD and RES/HP-β-CD/Chitosan were 172.5% and 540.0%. CONCLUSIONS: RES/HP-β-CD/Chitosan shows good sustained-release effect, and its bioavailability is significantly higher than that of RES raw materials, RES/HP-β-CD.
6.Role and mechanism of FOXG1 in invasion and metastasis of colorectal cancer.
Haixia WU ; Cheng QIAN ; Chungang LIU ; Junyu XIANG ; Di YE ; Zhenfang ZHANG ; Xianquan ZHANG
Chinese Journal of Biotechnology 2018;34(5):752-760
This study was aimed to investigate the effect of Forkhead Box G1 (FOXG1) on the epithelial-mesenchymal transition (EMT) of colorectal cancer (CRC) cells and the underlying mechanism. For this purpose, FOXG1 lentiviral interference (shRNA) plasmid and expression plasmid were constructed. Western blotting was used to analyze the expression of FOXG1 protein in five CRC cells, namely RKO, SW480, SW620, LoVo and DLD-1. The shRNA fragment of FOXG1 (shFOXG1) was designed and synthesized. Recombinant plasmids were obtained with the aid of DNA recombination technique. Double digestion and sequencing were used to identify the recombinant plasmids, and then lentivirus packaging, purification and stable transfection were carried out. Additionally, stable CRC cell lines were screened out. The changes of FOXG1 knockdown and overexpression efficiency, E-cadherin, Vimentin, Fibronectin, Snail, Twist mRNA and protein were investigated respectively by Western blotting and qRT-PCR analysis. Furthermore, the changes of cell morphology after knockdown and cell migration ability were evaluated respectively with optical microscopy, scratch test and Transwell assay. FOXG1 had the highest protein expression in RKO and the lowest in DLD-1 among the five CRC cells. Compared with those of the control group, the cell morphology in FOXG1 knockdown RKO group was changed from spindle into round or polygonal shape, cell polarization was enhanced and tight junction assembly was acclerated while cell migration distance was noticeably decreased. Moreover, the number of cells invaded and migrated through chambers was significantly reduced. Among these key factors of EMT, the expression of E-cadherin was increased while the expressions of Vimentin, Fibronectin, Snail and Twist were decreased. The opposite was the case in the overexpressed FOXG1 group. The overexpression of FOXG1 in CRC promoted the invasion and metastasis of CRC cells and played a crucial role in regulating the EMT. Thus, FOXG1 might be a novel therapeutic target in CRC treatment.
7.Research progress on enteric-soluble soft capsule
Xiaoqian TAO ; Huimin FU ; Zitong QIAO ; Qiang ZHANG ; Ziwei BAO ; Lan CHENG ; Chungang ZHANG
China Pharmacy 2022;33(7):891-896
Enteric-soluble soft capsule is a kind of new preparation that does not disintegrate in the stomach ,but releases rapidly in the intestinal tract to play a pharmacodynamic role. It has the unique advantages of improving drug stability ,reducing drug irritation ,delivering drugs directionally to the intestinal tract ,and prolonging drug action time. In this paper ,the decomposition and release mechanism ,application advantages ,classification of enteric-soluble coating materials and preparation methods of enteric-soluble soft capsule are sorted and summarized ,in order to provide reference for further development of this type of preparation.
8.Preparation and Quality Evaluation of Resveratrol-Hydroxypropyl- β-Cyclodextrin-Chitosan Sustained-release Pellets
Chungang ZHANG ; Chenchen YU ; Yixuan ZHOU ; Li YIN ; Lan CHENG ; Tingguo KANG ; Lan HAN
China Pharmacy 2019;30(17):2322-2326
OBJECTIVE: To prepare Resveratrol-hydroxypropyl-β-cyclodextrin-chitosan sustained-release pellets (RES-HP-β- CD-Chitosan), and to characterize it. METHODS: Resveratrol raw material, HP-β-cyclodextrin and chitosan were collected with ratio of 1 ∶ 7 ∶ 0.25. Resveratrol-HP-β-cyclodextrin inclusion compound were prepared by solvent method, and then added into chitosan, RES-HP-β-CD-Chitosan were prepared by spray drying method. Particle size of prepared sustained-released pellets were observed by optical microscope. X-ray, DSC, IR and SEM were used to characterize RES-HP-β-CD-Chitosan. The contents of resveratrol in prepared sustained-released pellets were determined by UV spectrum, and drug-loading amount and encapsulation efficiency were calculated. RESULTS: Particle size of prepared RES-HP-β-CD-Chitosan was (2.23±0.35) μm (n=300). Characterization results show that RES-HP-β-CD-Chitosan was spherical in shape; shrinkage was found on the surface of microspheres, and resveratrol was included in HP-β-cyclodextrin in molecule or amorphous state. Drug-loading amount of prepared RES-HP-β-CD-Chitosan was 11.67% (n=3), encapsulation efficiency was 96.27% (n=3). CONCLUSIONS: RES-HP-β-CD- Chitosan is prepared successfully.